Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity

North, 2000, Neurofibromatosis type 1, Am. J. Med. Genet., 97, 119, 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3

Stumpf D. Neurofibromatosis. Conference Statement, National Institute of Health development conference. Arch Neurol [Internet]. 1988 [cited 2021 Jan 24];45:575–8. Available from: http://ci.nii.ac.jp/naid/10024296720/en/.

Lehtonen, 2013, Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence, Dev. Med. Child Neurol., 55, 111, 10.1111/j.1469-8749.2012.04399.x

Martin, 2012, Social–emotional functioning of children and adolescents with Neurofibromatosis Type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables, J. Pediatr. Psychol., 37, 713, 10.1093/jpepsy/jsr124

Nguyen, 2011, Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits, J. Pediatr., 159, 652, 10.1016/j.jpeds.2011.04.008

Wolters, 2015, Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life, Am. J. Med. Genet., 167, 2103, 10.1002/ajmg.a.37123

Hyman, 2006, Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder, Dev. Med. Child Neurol., 48, 973, 10.1017/S0012162206002131

Hou, 2020, Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas, Dev. Med. Child Neurol., 62, 977, 10.1111/dmcn.14489

Krab, 2008, Impact of neurofibromatosis type 1 on school performance, J. Child Neurol., 23, 1002, 10.1177/0883073808316366

Riccardi, 1977, Neurofibromatosis: a neoplastic birth defect with two age peaks of severe problems, Birth Defects Orig. Artic. Ser., 13, 131

Brewer, 1997, Learning disability subtypes in children with neurofibromatosis, J. Learn. Disabil., 30, 521, 10.1177/002221949703000508

Ozonoff, 1999, Cognitive impairment in neurofibromatosis type 1, Am. J. Med. Genet., 89, 45, 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J

Rowbotham, 2009, Cognitive control in adolescents with neurofibromatosis type 1, Neuropsychology, 23, 50, 10.1037/a0013927

Roy, 2010, Executive dysfunction in children with neurofibromatosis type 1: a study of action planning, J. Int. Neuropsychol. Soc.: JINS., 16, 1056, 10.1017/S135561771000086X

Descheemaeker, 2005, Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children, J. Intellect. Disabil. Res., 49, 33, 10.1111/j.1365-2788.2005.00660.x

Arnett, 2013, Behavioral and cognitive predictors of educational outcomes in pediatric traumatic brain injury, J. Int. Neuropsychol. Soc.: JINS, 19, 881, 10.1017/S1355617713000635

Kinsella, 1997, Predictors and indicators of academic outcome in children 2 years following traumatic brain injury, J. Int. Neuropsychol. Soc., 3, 608, 10.1017/S1355617797006085

Ullrich, 2010, Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1, J. Child Neurol., 25, 1195, 10.1177/0883073809358454

Delis, 1994

Delis, 2000

Donders, 1999, Structural equation analysis of the California verbal learning test-children’s version in the standardization sample, Dev. Neuropsychol., 15, 395, 10.1080/87565649909540757

Griffiths, 2006, The factor structure of the CVLT-C in pediatric epilepsy, Child Neuropsychol., 12, 191, 10.1080/09297040600681315

Williams, 2001, Patterns of memory performance in children with controlled epilepsy on the CVLT-C, Child Neuropsychol., 7, 15, 10.1076/chin.7.1.15.3148

Conklin, 2007, Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial, J. Pediatr. Psychol., 32, 1127, 10.1093/jpepsy/jsm045

Cutting, 2003, Evidence for unexpected weaknesses in learning in children with attention-deficit/hyperactivity disorder without reading disabilities, J. Learn. Disabil., 36, 259, 10.1177/002221940303600305

Ablon, 1996, Gender response to neurofibromatosis 1, Soc. Sci. Med., 42, 99, 10.1016/0277-9536(95)00076-3

Martin, 2015, Development and validation of the English pain interference index and pain interference index-parent report, Pain Med., 16, 367, 10.1111/pme.12620

Wechsler, 2004

Wechsler, 2008, vol. 22, 1

Wechsler, 1999

Noll, 2007, Social, emotional, and behavioral functioning of children with NF1, Am. J. Med. Genet., 143, 2261, 10.1002/ajmg.a.31923

Haukoos, 2005, Advanced statistics: bootstrapping confidence intervals for statistics with “difficult” distributions, Acad. Emerg. Med., 12, 360, 10.1197/j.aem.2004.11.018

Cohen, 1988

Brouwers, 1990, Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits, Am. J. Pediatr. Hematol. Oncol., 12, 174, 10.1097/00043426-199022000-00009

Walsh, 2016, Neurocognitive outcomes in neurofibromatosis clinical trials: recommendations for the domain of attention, Neurology, 87

Donders, 1999, Performance discrepancies on the California verbal learning test–children’s version in the standardization sample, J. Int. Neuropsychol. Soc., 5, 26, 10.1017/S1355617799511041

Dombi, 2007, NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight, Neurology, 68, 643, 10.1212/01.wnl.0000250332.89420.e6

Lorenzo, 2013, Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study, J. Pediatr., 163, 1479, 10.1016/j.jpeds.2013.06.038